NeuroKines
© NeuroDiderot
Brain damage in newborns can be caused by intrinsic factors (strokes, epilepsy, tumors) or extrinsic factors (fetal or maternal infections, head trauma, exposure to toxic substances). These conditions increase the risk of neurodevelopmental disorders (NDD), affecting the child’s neurological and cognitive functions.
The NeuroKines team (Team 1) is dedicated to studying the cellular mechanisms responsible for these lesions, with a goal to identifying new therapeutic targets. Using in vitro and in vivo models reproducing these neonatal and pediatric neuropathological processes, our aim is to test candidate molecules and develop innovative neuroprotective strategies. Our goal is also to transfer these advances into clinical trials to improve the management of at-risk newborns.
The NeuroKines team is composed of 4 groups with complementary themes, led by:
– Juliette Van Steenwinckel and Pierre Gressens (G1)
– Alice Jacquens and Vincent Degos (G2)
– Pascal Dournaud (G3)
– Stéphane Auvin (G4)
KEY WORDS: Neurodevelopmental disorders, Prematurity, Traumatic brain injury, Fetal alcohol syndrome, Epilepsy, Autism, Cognitive deficits, Neuroinflammation, Microglia, Cytokines.
Contacts
Pierre Gressens
UMR 1141 Inserm-Université Paris Cité
Hôpital Robert Debré
48 boulevard Sérurier
75019 Paris
pierre.gresens@inserm.fr
Juliette Van Steenwinckel
UMR Inserm 1141–Université Paris Cité
Hôpital Robert Debré
48 boulevard Sérurier
75 019 Paris
juliette.van-steenwinckel@inserm.fr
(G1) Role of microglia in neonatal brain injury
(G3) Moderate prenatal alcohol exposure: focus on the neuro-immune axis
(G2) Long-term consequences of post-traumatic brain injury
(G4) New therapies for neurodevelopmental epilepsy
NeuroDiderot Teams
Read more
Conference Postponed Alexandra Benchoua from I-Stem : Human pluripotent stem cell models for high-throughput screening of therapeutic molecules and precision medicine in neurodevelopmental disorders.
Meeting Room 6th floor Bingen Building and Visio https://u-paris.zoom.us/j/84730677369?pwd=AFdhdI6alNWLbXub7sM1DJ33yUIOYN.1 - Summary séminaire A-Benchoua _27-nov-2025 english
New Golgipathy identified in NeuroDev team
The NeuroDev team publishes an article in Life Science Alliance [1] identifying the first human pathogenic variant of GORASP1, the gene encoding the Golgi stacking protein GRASP65, and demonstrating its consequences on glycosylation and mitotic progression. [1] S....
Job opportunity within The Integrative Genomics in Neurodevelopment group
The Integrative Genomics in Neurodevelopment group is seeking a highly motivated post-doctoral researcher. Check out the opportunity here: Post-doc researcher position in Computational Biology
Sleep2Develop research program
The Sleep2Develop program investigates the role of sleep as a promotor of neurodevelopment and identifies the sleep determinants of childhood development. This is rephrased as Sleep(to)Develop? or Sleep(to)Develop! Our sleep research combines clinical and...